Beta-blockers in the post-myocardial infarction patient.
Gheorghiade
Mihai
M
Division of Cardiology, Northwestern Feinberg Medical School, Chicago, Ill 60611, USA. m-gheorghiade@northwestern.edu
Goldstein
Sidney
S
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D001741:Black or African American; D000368:Aged; D002986:Clinical Trials as Topic; D000075202:Contraindications; D048909:Diabetes Complications; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications; D008297:Male; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control*; D016491:Peripheral Vascular Diseases / Q000150:complications; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists